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ABSTRACT
Background:
Numerous techniques have been described for nasal septal perforation repair, with
various degrees of success in achieving closure. Evidence supports the use of bilateral
mucoperichondrial advancement flaps with interpositional grafting for greatest success.
Many surgeons use autografts such as fascia, cartilage, bone, and pericranium, however,
extracellular matrices have also become popular.
Objective:
We analyze factors determining the success of nasal septal perforations repaired using
using an acellular, freeze-dried interpositional xenograft derived from Porcine Small
Intestinal Submucosa (PSIS).
Methods:
Patients with septal perforation repaired by the senior author from 1998 to 2006 were
examined in a retrospective chart review with regard to perforation size, etiology, preand postoperative symptoms, follow-up, outcomes and complications.
Results:
Forty-seven PSIS repairs were performed on 46 patients. Two procedures were planned
staged procedures. Of the total 47 procedures, 41 (87.2%) continued to be closed at the
site of repair during the follow up period. Follow up ranged from 6 months to 4.9 years
with a mean of 18.3 months. Two patients (4.3%) were found to have perforations at the
site of closure in the immediate post-operative period. One patient (2.1%) perforated at
the site of closure after the immediate post-operative period. Subjective symptom scores
demonstrated improvement in crusting, epistaxis and obstruction postoperatively. Larger
perforations correlated with poorer outcomes.
Conclusions:
The authors conclude that closure of nasal septal perforation with an interpositional
xenograft derived from PSIS compares favorably to published results for autografts with
advantages including absence of donor site morbidity, easy graft modification and
manipulation, and shorter operative time.
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Introduction:
Numerous techniques have been advocated for repair of nasal septal perforations
[1-3]. For symptomatic patients who fail conservative management, the surgical goals
can largely be agreed upon to include: 1) Restoration of normal function and physiology
to the nose and 2) Reduction of symptoms [4]. However, a consensus on the ideal
procedure to achieve complete closure of nasal septal perforations remains elusive.
Reconstruction of the nasal septum in three distinct layers using bilateral
mucoperichondrial flaps with interpositional grafting has gained widespread acceptance
[1, 2, 4, 5]. This method consistently demonstrates closure rates greater than 70% and
frequently higher than 90% in numerous series. These rates match favorably with respect
to closure by mucoperichondrial advancement omitting the use of interposition grafting
[1]. The mechanism for this greater success is theorized to include 1) improved mucosal
cellular migration with the graft acting as a scaffold 2) the graft providing a barrier
between the bilateral incision lines during healing and 3) the allowance of incomplete
mucosal closure on one side of the septum where excessive tension would be required [1,
4]. Even amongst surgeons who employ this method to achieve closure of nasal septal
perforations, there is considerable diversity in the choice of interpositional graft material.
Autologous grafts used for the repair of nasal septal perforations include
temporalis fascia, septal cartilage and bone, pericranium, mastoid bone and
perichondrium, tragal cartilage and perichondrium, ethmoid bone, iliac crest, conchal
cartilage, and skin graft [2, 6]. Recently, use of manufactured allografts such as freezedried acellular human dermis, xenografts such porcine small intestinal submucosa (PSIS),
and synthetic materials such as bioactive glass has been described [6-9]
Porcine small intestinal submucosa (“SurgiSIS”, Cook Biotech Inc, West
Lafayette, IN) is a biologic, acellular, freeze-dried, soft tissue graft. It is purified, washed
in solutions to eradicate viruses, and sterilized. Small intestinal submucosa mimics the
extracellular matrix (ECM) environment. Fibrillar collagens and adhesive glycoproteins
serve as a scaffold for cellular migration, and regulatory factors such as
glycosaminoglycans, proteoglycans, and growth factors are reportedly retained following
processing [10]. Following implantation, SIS encourages angiogenesis, epithelial and
connective tissue growth and differentiation, and evolution of recipient site ECM.
Porcine SIS has been used in a wide variety of surgical applications including hernia
repair, urethral and ureteral reconstruction, pelvic floor reconstruction, and chronic
wound dressing.
The senior author (EP) previously reported a case series of 10 patients with nasal
septal perforations repaired using an external rhinoplasty approach, bilateral bipedicled
mucoperichondrial advancement flaps and interpositional graft consisting of porcine
small intestinal submucosa [7]. A rate of closure of 100% was achieved in the early
follow-up period. This article updates the series to include 46 patients repaired using this
approach, and reviews the series demographics, etiology, outcomes, and risk factors for
perforation and complications of repair.
Patients and Methods
Following approval from the Institutional Review Board at Thomas Jefferson
University, a retrospective chart review was performed on all patients undergoing nasal
septal perforations repair using porcine small intestinal submucosa as an interpositional
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graft by the senior author (EP), during the time period from 1998-2006. Of a total of 53
patients undergoing septal perforation repair during this same time period, 46 patients
underwent 47 repairs using PSIS interpositional graft and the surgical method. The
remaining seven patients were closed using silicone sheeting, rib graft, or local
advancement flaps alone because of large unstable defects or inadequate mucosa. Two
patients in the series had tissue expanders placed, with the expanded mucosa employed at
the time of septal perforation repair. One patient underwent revision septal perforation
repair with repeated PSIS placement.
Patients with symptomatic nasal septal perforations were considered candidates
for repair with PSIS graft. Patients with a history of cocaine abuse were required to
abstain for at least 6 months prior to consideration of repair, as well as demonstrate a
negative preoperative drug screen. Laboratory workup included screening for
granulomatous diseases, rheumatologic diseases and syphilis.
Patients received perioperative antibiotics and corticosteroids. Nasal septal
perforation closure was achieved using either an endonasal (n=6) or open rhinoplasty
(n=41) approach with bilateral mucoperichondrial advancement flaps covering an
interpositional PSIS graft [7]. The PSIS was rehydrated in a gentamicin-normal saline
solution for 10 minutes, then shaped and trimmed to the appropriately sized
interpositional graft [7]. Septal biopsies were performed intraoperatively. Patients had
0.25 mm silicone splints secured on either side of the repair, which were removed after 3
weeks.
A retrospective chart review abstracted presenting symptoms and an attempt was
made to determine the general effect of surgical repair on these symptoms. Two authors
(PSM and AAS) subjectively determined the severity of these symptoms both pre and
post-operatively as described by office notes and symptom questionnaires. A 4-point
scale was created, with “0” representing a lack of symptoms (e.g. for epistaxis, “0” means
patient did not experience epistaxis), and scores of 1, 2, and 3 representing mild,
moderate, and severe symptoms, respectively.
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Results:
Twenty-four percent (11/46) of patients were male. Patient ages ranged from 1769 years with a mean of 40.4 (stddev=11.4). 63% (29/46) were self-described lifetime
nonsmokers, while 19.6% (9/46) were former smokers and 17.4% (8/46) current smokers.
The size of perforations ranged from 0.5 cm to 4.7 cm in largest dimension, with a mean
approximately 1.7 cm (stddev=0.8 cm). Patients were followed for an average of 18.3
months (stddev=14.2 months), with a range in follow up from 6 months to 4.9 years. See
Table 1 for a summary of patient characteristics.

Table 1. Patient Characteristics
40.4
Age (mean, std)
Gender (N=46)
Male
11
Female
35
Smoking Status (N=46)
Non-Smoker
29
Former Smoker
9
Current Smoker
8
Perforation Sizes (N=47)
<10 mm
5
10-19 mm
29
20-29 mm
7
30-39 mm
4
>=40 mm
1
Largest Dimension of Perforation (mean, std)* 1.7 cm
18.3 mos
Follow Up (mean, std)
N=46 patients, or 47 procedures
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11.4
23.9%
78.3%
63.0%
19.6%
17.4%
10.6%
61.7%
14.9%
8.5%
2.1%
0.8 cm
14.2 mos

Previous surgery, cocaine use, and previous trauma were the most common
determined etiologies for these patients (Table 2).

Table 2. Contributing Etiology

N=47

%

20

42.6%

13

27.7%

11

23.4%

5

10.6%

4

8.5%

3

6.4%

2

4.3%

1

2.1%

Surgery
Cocaine Use
Trauma (i.e. fracture, picking,
cautery)
Idiopathic
Infection/Septal Abscess
Granulomatous/Systemic
Sprays
Occupational Exposure

Some patients had more than one contributing etiology

The three most frequently reported presenting symptoms were, in descending
order: nasal obstruction, crusting, and epistaxis (Table 3).

Table 3. Presenting Symptoms
Obstruction
Crusting
Epistaxis
Chronic Sinusitis/Chronic Sinus
Complaints

PND
Anosmia
Whistling
Rhinorrhea

N=47

%

38

80.9%

27

57.4%

21

44.7%

19

40.4%

13

27.7%

6

12.8%

3

6.4%

3

6.4%

Some patients had more than one presenting symptom
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Outcomes
Closure
Forty-seven PSIS repairs were performed on 46 patients. Of the total 47
procedures, 41 (87.2%) continued to be closed at the site of repair during the follow up
period. Two procedures were staged, with a planned incompletely closed perforation at
the first stage. Excluding these staged procedures, 41/45 (91.1%) continued to be closed
at the site of repair during the follow up period.
Failure
Of the total 47 procedures, six perforations (12.8%) remained during the follow
up period. Two of the perforations were in the patients scheduled to undergo staged
procedures and will be discussed below. The remaining four perforations developed in
patients who underwent primary procedures.
Of the total 45 planned complete closures, one patient developed a perforation at
the site of closure after the immediate post-operative period (termed “Reperforation”).
Three patients developed perforations at sites separate from the site of surgical repair
(termed “Second Perforation”). Of note, one of these appeared to be at the site of a splint
suture and remains stable at 2mm.
As mentioned above, two failures were in patients scheduled to undergo staged
procedures with the expectation of incomplete closure in the immediate post-operative
period (termed “Residual Perforation”). Only one of these patients had undergone
secondary procedure at the time of writing. The other staged patient had her perforation
significantly reduced (1.5 cm to 0.2cm) by the initial procedure, and has not pursued the
second stage of operation given the relief of presenting symptoms.
The outcomes of the procedures are listed in Table 4.

Table 4. Outcomes
Primary Procedures
Staged Procedures
Total

N
45
2
47

%

Description
Planned complete closure
Planned incomplete closure
Total # PROCEDURES (not patients)

Closures

41 87.2%

Failures
Reperforation
Second Perforation
Residual Perforation

6 12.8%
1 2.1%
3 6.4%
2 4.3%

Total # of HEALED perforations at site of repair, including staged

Total # of perforations during the follow up period, including staged
Perforation at repair site, initially closed
Perforation separate from repair site
Intentional perforation in the immediate post-operative period
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As the ultimate goal of this analysis to is to identify risk factors that might allow proper
selection of patients and individualized procedures, it is instructive to examine carefully
the failures, which include patients who required staged procedures, developed
reperforation, or second perforations
Table 5 describes the patients in this study who had subtotal closure of their nasal
septum. Two procedures were planned staged procedures. Both of these patients had
septal perforation repair attempts prior to initial consultation, and 3 cm perforations.
One patient developed reperforation. Patient 3 had a near-total perforation,
approximately 4.7 cm x 3.4 cm with saddle nose deformity. She had concurrent
rhinoplasty and repair of nasal vestibular stenosis. Unfortunately, she restarted intranasal
cocaine use postoperatively. No closure was planned given the cocaine use and
asymptomatic nature of this reperforated septum.
Two patients, Patients 4 and 5, had residual perforations. Patient 4 represents the
second stage of Patient 1. She underwent placement of tissue expanders in the nasal
floor. Patient 5 is a patient with sarcoidosis, who required tissue expanders as well for
adequate mucosal tissue for advancement. She achieved approximately 80% closure and
did not proceed with a subsequent procedure given the relief of her symptoms. Of note,
both procedures with tissue expander placement resulted in residual perforation. The
senior author has discontinued use of tissue expanders in the setting of nasal septal
perforation repair.
Three patients (Patients 6, 7, and 8) developed new perforations at a site separate
from the original perforation. The second perforations arose at sites near the original
perforation and may represent areas of denuded septum during the advancement flap
rotation or devascularized tissue from elevation and rotation of the mucoperichondrial
flaps. One of these clearly resulted from the splint suture in the anterior septum.
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Table 5. Description of Patients with Incomplete Closure
ID

Age

Sex

Etiology

Perforation Size (mm)
Largest
Dimension

Other
Dimension

Repair

Outcome

Defect
Size
(mm)

Notes

1*

53

F

infection MRSA

30

13

Open/Surgisis/MP flap/Buccal flap

Staged

22

prior perforation repair

2

39

F

cocaine/surgery

30

15

Surgisis/MP flap

Staged

10

h/o prior perf repair, refused rhinoplasty, no floor mucosa

3

32

F

47

34

Surgisis/MP flap

Reperforation

5

near total perf;cont'd cocaine; revision rhinoplasty

4*

57

F

cocaine
infection MRSA

22

NR

Surgisis/MP flap/T XP

Residual

3

had previous perforation repair x2, 2nd stage

5

44

F

sarcoid/surgery

32

22

Surgisis/MP flap/T XP

6

sarcoidosis

6

17

F

idiopathic

15

10

Surgisis/MP flap

3

superior to repair, rheum w/u ongoing

7

35

M

surgery

20

18

Surgisis/MP flap

2

posterior to repair

8

41

F

surgery

15

NR

Surgisis/MP flap

Residual
2nd
perforation
2nd
perforation
2nd
perforation

2

anterior to repair, from splint suture

* - denotes that this is the same patient, who underwent 2 separate procedures
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Symptoms
The results of the preoperative and postoperative profile for the three most
commonly reported presenting symptoms are documented in Table 6. Each of the 3
symptoms is measured on a 4-point scale (0, 1, 2, 3) based on severity of the symptom.
A clear shift toward improvement is seen postoperatively. We considered the difference
in score (change score = post-op score – pre-op score) as a measure of the change in
severity of the symptom. The number of pre-repair symptoms and post-repair symptoms
differ, because one patient underwent two procedures. The patient who did not complete
the 2 stage procedure is excluded from this table.
Table 6. Symptom Scores
Crusting
0 (Not a symptom)
1 (Mild)
2 (Moderate)
3 (Severe)
Epistaxis
0 (Not a symptom)
1 (Mild)
2 (Moderate)
3 (Severe)
Obstruction
0 (Not a symptom)
1 (Mild)
2 (Moderate)
3 (Severe)

Pre-Repair Symptoms Post-Repair Symptoms
N
%
N
%
17

37.8

38

82.6

12

26.7

7

15.2

13

28.9

1

2.2

3

6.7

0

0

24

53.3

41

89.1

13

28.9

5

10.9

7

15.6

0

0

1

2.2

0

0

7

15.9

21

45.7

16

36.4

17

37

18

40.9

6

13

3

6.8

2

4.4
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We found that major symptoms improved after surgery (Table 7), as expected.
Even the patients with subtotal closure of the nasal septal perforation routinely
experienced a dramatic improvement of their symptoms, sometimes obviating the
indications for further surgical repair. Table 7 displays the frequencies of each possible
change score (-3 to +2, with negative values indicating improvement in severity of
symptoms) and tests whether, on average, the change score is different from 0. We used
the Wilcoxon signed rank test for this, since the data, being a difference of scores, is quite
non-normal. We found that all the symptoms showed improvement on average after
surgery. 47% showed improvement in epistaxis, 54.55% in obstruction and 55.56% in
crusting.
We did note a persistent and paradoxical increase in obstructive symptoms in 5
patients (10.9%) postoperatively. Two of these patients were found to have exuberant
granulation and regrowth at the repair site that necessitated surgical intervention. The
remainder experienced primarily chronic sinus complaints.

Table 7. Change in Symptom Scores
Epistaxis*
Change from Pre-

Obstruction**

n

Cumulative
%

p

-3

1

2.27

<.0001

-2

4

-1

Crusting*

n

Cumulative
%

p

1

2.27

0.0002

11.36

9

16

47.73

0

22

+1
+2

Repair to Post-Repair

n

Cumulative
%

p

2

4.44

<.0001

22.73

13

33.33

14

54.55

10

55.56

97.73

14

86.36

17

93.33

1

100

5

97.73

2

97.78

0

100

1

100

1

100

*n=45, **n=44
p from Wilcoxon signed rank test

Taking into account all patients, including planned staged patients, statistical
analysis does correlate repair outcome with perforation size. Table 8 compares, using a
two-sample t-test, the mean perforation size between patients with closed perforation
post-surgery (~1.5 cm) and patients with the perforation not closed post-surgery (2.6 cm).
We find that this average difference of 1.1 cm is statistically significant (p-value=0.011),
reinforcing the observation that larger perforations are more likely to have worse
outcomes.
Table 8. Perforation
Size and Repair
Outcome

Largest OR Measurement*

mean

std

Perforation NOT Closed

26.22

10.02

Perforation Closed

15.21

5.63

Mean Difference

11.01

p = 0.011
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*n=45

Other results
Biopsy results were available for 35 patients. Two of these (5.7%) supported a
diagnosis for granulomatous disease, and the remainder demonstrated various degrees of
inflammation without contributing significantly to the diagnostic evaluation. One of the
biopsy positive patients was known to have sarcoidosis, and the other had no clinical
evidence supporting a systemic disease process. Of two patients known to have
sarcoidosis, one (50%) revealed granulomatous disease on biopsy. No nasal septal
biopsies led to diagnosis of an unknown systemic process. This is consistent with the
findings of Diamantopoulos et al. [11] that demonstrate the low yield of this convention.
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Discussion
The septal perforation closure rates cited in this study correspond favorably with
those reported by other authors. Reviews of the literature reveal that reconstruction of the
nasal septum in three distinct layers using mucoperichondrial flaps with interpositional
grafting achieves high rates of closure. However, no consensus on the material for
interpositional grafting is apparent. Autologous grafts (temporalis fascia, septal cartilage
and bone, pericranium, mastoid bone and perichondrium, tragal cartilage and
perichondrium, ethmoid bone, iliac crest, conchal cartilage and skin graft) all require a
donor site that can add to procedural morbidity, complications such as hematoma and
wound infection, and increased operative time. Autografts can result in thin, awkward
flaps (fascia), or bulky material that must be modified or thinned (bony and cartilaginous
grafts). Allografts and xenografts that can reconstruct the cartilaginous layer with similar
outcomes may offer a compelling alternative if their use is not associated with increased
risk. Currently, published available alternatives include acellular human dermal [6, 8],
bioglass [9], and porcine small intestinal submucosa [7]. All of these obviate the need for
graft harvest, and eliminate donor site morbidity.
The senior author (EP) previously published a series of 10 patients with nasal
septal perforations repaired using an external rhinoplasty approach, mucoperichondrial
bipedicled advancement flaps with interpositional graft using PSIS xenograft. The results
in this small case series with short follow up (3-12 months) were very promising, given
the 100% closure rate. The present study includes longer follow-up data and a much
larger number of patients. The overall closure rate of 87.2% is comparable to rates cited
by authors employing a wide variety of surgical approaches, techniques, and
interpositional grafts [1].
PSIS was chosen as a material for interpositional grafting given the multiple
advantages over autografts previously listed as well as theorized physiologic factors.
Advantages over autografts are listed above. Technical advantages of this graft include
the ease with which the graft may be trimmed, shaped and modified, the uniformity of
thickness, the ease of readiness (10 minute rehydration), and graft pliability. The
physiologic basis for use includes the preservation of extracellular matrix components
that enhance wound healing. The fibrillar collagens and glycoproteins provide a scaffold
for epithelial and connective tissue migration. Glycosaminoglycans, proteoglycans, and
growth factors are retained and help to regulate the response to injury. Thus, PSIS serves
requisite functions as a bioactive interpositional graft similar to autografts.
PSIS is contraindicated in patients with allergy or sensitivity to porcine products.
The porcine derivation of this product should certainly be disclosed to patients with
potential religious or cultural objections to its use.
In our experience, PSIS successfully formed a neoseptum with sufficient integrity
to remain stable during inspiratory and expiratory forces. In the one patient who
underwent second stage septal perforation repair, this neoseptum could be separated into
two flaps that could receive a second interpositional graft of PSIS between the leafs. In
fact, the method of reconstructing the nasal septum in three layers with a bioactive
interpositional graft could theoretically encourage neocartilage formation. Two patients
returned to the operating room in this series for management of nasal obstruction
secondary to robust neoseptum formation. Upon pathologic evaluation of specimen
retrieved from the site of prior septal perforation repair with PSIS, one of the specimens
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identified “fragments of fibrocartilage consistent with nasal septum”, while the other
revealed “reactive fibrosis, scattered chronic inflammatory cells and focal multinucleated
giant cell reaction.”
Conclusions
Surgical repair of nasal septal perforations using porcine small intestinal
submucosa for interpositional grafting appears to be a viable alternative technique, with
closure outcomes rivaling those generally accepted by otolaryngologists. The
comparable biologic activity, coupled with ease of use and lack of donor site morbidity
present a clear advantage over autograft materials.

Acknowledgment: The authors acknowledge Dr. Abhijit Dasgupta and the Division of
Biostatistics for their assistance in the statistical analysis of the displayed data.
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